Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FLME
|
Global Icav Pilgrim
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 167,175 Reduced 1.66% |
$3,674,506
$21.98 p/Share
|
Jul 18
2025 |
|
TASK
|
Bryce Maddock
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 68,899 Added 5.94% |
-
|
Jul 18
2025 |
|
TASK
|
Bryce Maddock
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 27,112 Reduced 2.49% |
$462,801
$17.07 p/Share
|
Jul 18
2025 |
|
TASK
|
Jaspar Weir
President |
BUY
Exercise of conversion of derivative security
|
Direct | 68,899 Added 6.3% |
-
|
Jul 18
2025 |
|
TASK
|
Jaspar Weir
President |
SELL
Payment of exercise price or tax liability
|
Direct | 27,112 Reduced 2.64% |
$462,801
$17.07 p/Share
|
Jul 18
2025 |
|
RCAT
|
Jeffrey M Thompson
Chairman of the Board, CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 441,983 Added 3.31% |
$1,109,377
$2.51 p/Share
|
Jul 18
2025 |
|
RCAT
|
Jeffrey M Thompson
Chairman of the Board, CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 46,297 Reduced 0.36% |
$541,674
$11.7 p/Share
|
Jul 18
2025 |
|
CVX
|
Debra L Reed
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 316 Added 0.0% |
-
|
Jul 18
2025 |
|
CVX
|
Thomas Ryder Booth
Vice President |
BUY
Grant, award, or other acquisition
|
Indirect | 5 Added 0.0% |
-
|
Jul 18
2025 |
|
DKNG
|
R Stanton Dodge
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 105,554 Reduced 17.43% |
$4,594,765
$43.53 p/Share
|
Jul 18
2025 |
|
DKNG
|
R Stanton Dodge
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 100,719 Added 14.26% |
$402,876
$4.0 p/Share
|
Jul 18
2025 |
|
CVX
|
Iii Donald J Umpleby
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 9 Added 0.0% |
-
|
Jul 18
2025 |
|
PBYI
|
Alessandra Cesano
Director |
SELL
Open market or private sale
|
Direct | 27,000 Reduced 39.22% |
$90,990
$3.37 p/Share
|
Jul 18
2025 |
|
MCB
|
Robert C Patent |
BUY
Other acquisition or disposition
|
Indirect | 34,502 Added 0.0% |
-
|
Jul 18
2025 |
|
MCB
|
Robert C Patent |
BUY
Other acquisition or disposition
|
Direct | 34,502 Added 23.28% |
-
|
Jul 18
2025 |
|
MCB
|
Robert C Patent |
SELL
Other acquisition or disposition
|
Indirect | 69,004 Reduced 0.0% |
-
|
Jul 18
2025 |
|
CVX
|
Marillyn A Hewson
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 59 Added 0.0% |
-
|
Jul 18
2025 |
|
CELH
|
Dean De Santis
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 300,000 Reduced 0.0% |
$12,047,999
$40.16 p/Share
|
Jul 18
2025 |
|
CELH
|
William H. Milmoe
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 300,000 Reduced 0.0% |
$12,047,999
$40.16 p/Share
|
Jul 18
2025 |
|
RBRK
|
Asheem Chandna |
BUY
Other acquisition or disposition
|
Indirect | 384,022 Added 0.0% |
-
|
Jul 18
2025 |
|
PWR
|
Jayshree S Desai
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 414 Reduced 0.86% |
$164,730
$397.9 p/Share
|
Jul 18
2025 |
|
ZIP
|
Amy Garefis
EVP, Chief People Officer |
SELL
Open market or private sale
|
Direct | 2,532 Reduced 1.2% |
$11,647
$4.6 p/Share
|
Jul 18
2025 |
|
AMAT
|
James Robert Anderson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 806 Added 50.0% |
-
|
Jul 18
2025 |
|
WRBY
|
Neil Harris Blumenthal
Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct | 400 Added 1.37% |
-
|
Jul 18
2025 |
|
WRBY
|
Neil Harris Blumenthal
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 400 Reduced 1.39% |
$9,604
$24.01 p/Share
|
Jul 18
2025 |
|
DFH
|
William Radford Lovett Ii |
SELL
Open market or private sale
|
Indirect | 6,512 Reduced 0.0% |
$170,809
$26.23 p/Share
|
Jul 18
2025 |
|
MTCH
|
Glenn Schiffman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 30 Added 0.07% |
$973
$32.45 p/Share
|
Jul 18
2025 |
|
LOOP
|
Jay Howard Stubina
Director |
BUY
Grant, award, or other acquisition
|
Direct | 62,154 Added 23.45% |
-
|
Jul 18
2025 |
|
QUIK
|
Russell Christine |
BUY
Exercise of conversion of derivative security
|
Direct | 3,240 Added 22.55% |
-
|
Jul 18
2025 |
|
LOOP
|
Laurence G. Sellyn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 62,154 Added 18.16% |
-
|
Jul 18
2025 |
|
WRBY
|
David Abraham Gilboa
Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct | 500 Added 1.7% |
-
|
Jul 18
2025 |
|
WRBY
|
David Abraham Gilboa
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.73% |
$12,005
$24.01 p/Share
|
Jul 18
2025 |
|
LOOP
|
Laurent Auguste
Director |
BUY
Grant, award, or other acquisition
|
Direct | 62,154 Added 38.75% |
-
|
Jul 18
2025 |
|
LOOP
|
Louise S Sams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 62,154 Added 28.7% |
-
|
Jul 18
2025 |
|
MTCH
|
Laura Rachel Jones
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12 Added 0.13% |
$389
$32.45 p/Share
|
Jul 18
2025 |
|
LOOP
|
Spencer Hart
Director |
BUY
Grant, award, or other acquisition
|
Direct | 62,154 Added 20.41% |
-
|
Jul 18
2025 |
|
ZIP
|
Ryan T. Sakamoto
EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,978 Reduced 2.47% |
$13,698
$4.6 p/Share
|
Jul 18
2025 |
|
CVNA
|
Ernest C. Garcia Iii
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$3,417,600
$341.76 p/Share
|
Jul 18
2025 |
|
BDX
|
Michael David Garrison
EVP & President, Medical |
BUY
Exercise of conversion of derivative security
|
Direct | 6,360 Added 36.12% |
$939,244
$147.68 p/Share
|
Jul 18
2025 |
|
BDX
|
Michael David Garrison
EVP & President, Medical |
SELL
Open market or private sale
|
Direct | 1,185 Reduced 19.52% |
$214,354
$180.89 p/Share
|
Jul 18
2025 |
|
BDX
|
Michael David Garrison
EVP & President, Medical |
SELL
Sale (or disposition) back to the issuer
|
Direct | 5,175 Reduced 46.01% |
$933,000
$180.29 p/Share
|
Jul 18
2025 |
|
GRF
|
Donald G Tyler
Director |
SELL
Open market or private sale
|
Direct | 1,802 Reduced 13.98% |
$18,164
$10.08 p/Share
|
Jul 18
2025 |
|
PSIX
|
Constantine Xykis
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 14,996 Added 23.49% |
$44,838
$2.99 p/Share
|
Jul 18
2025 |
|
PSIX
|
Constantine Xykis
CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 14,996 Reduced 30.69% |
$1,349,640
$90.0 p/Share
|
Jul 18
2025 |
|
BLFS
|
Sean Werner
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,115 Reduced 4.04% |
$23,660
$21.22 p/Share
|
Jul 18
2025 |
|
SOUN
|
Michael Zagorsek
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 134,172 Added 8.31% |
$391,782
$2.92 p/Share
|
Jul 18
2025 |
|
UAL
|
Torbjorn J Enqvist
EVP & Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 24.28% |
$1,844,400
$92.22 p/Share
|
Jul 18
2025 |
|
OPRT
|
Mohit Daswani
Director |
BUY
Grant, award, or other acquisition
|
Direct | 18,090 Added 23.16% |
-
|
Jul 18
2025 |
|
OPRT
|
Jo Ann Barefoot
Director |
BUY
Grant, award, or other acquisition
|
Direct | 18,090 Added 15.91% |
-
|
Jul 18
2025 |
|
OPRT
|
Carlos Minetti
Director |
BUY
Grant, award, or other acquisition
|
Direct | 18,090 Added 21.11% |
-
|
Jul 18
2025 |